Cosentyx (Secukinumab PFS) 75mg/0.5ml

COSENTYX (Secukinumab) 75mg/0.5ml PFS is a prescription biologic used to treat inflammatory conditions. Store at 2-8°C and protect from light. Always follow healthcare provider guidance when using.

Strength

75mg/0.5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Novartis

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Secukinumab is used to reduce inflammation and manage symptoms in conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by targeting specific immune pathways to help control flare-ups and improve quality of life. This medication is prescribed for adults and some adolescents depending on the condition.

Side Effects

Many users experience reduced joint pain, skin redness, and swelling after starting Secukinumab. Some notice improved mobility and fewer disease flare-ups over time. Individual responses vary, and results depend on consistent use as directed by a healthcare professional.

Precautions & Warnings

Keep Secukinumab refrigerated between 2–8°C and avoid freezing. Protect the pre-filled syringe from light. Do not use if the liquid is discolored or contains particles. Always check expiration dates and follow disposal instructions for used syringes.

Avoid Interactions

Secukinumab may interact with live vaccines, so avoid vaccinations during treatment unless approved by a doctor. Caution is advised when combining with other immunosuppressants. Discuss all current medications and health conditions with your healthcare provider before starting Secukinumab.

Frequently Asked Questions

Secukinumab is used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis by reducing inflammation.

Store the pre-filled syringe in the refrigerator between 2–8°C. Do not freeze and keep it away from light.

Consult your healthcare provider before using Secukinumab if you have an active infection, as it may affect your immune response.

The safety of Secukinumab during pregnancy has not been established. Discuss risks and benefits with your doctor if pregnant or planning pregnancy.

Dosage and frequency depend on the condition being treated. Follow your healthcare provider’s prescribed schedule for injections.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.